These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33913015)

  • 41. IMPROVEMENT OF HYPERTROPHIC SCARS WITH INTRALESION INJECTIONS OF HYALURONIDASE.
    Wollina U; Goldman A
    Georgian Med News; 2020 Apr; (301):41-43. PubMed ID: 32535560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical application and mechanism of botulinum toxin type A in scar treatment].
    Zhang YX; Zhang SN
    Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):705-710. PubMed ID: 34404162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin type a intralesional monotherapy for treating human hypertrophic scar in a dose-dependent manner: In an animal model.
    Hua Z; Wei P
    J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3196-3211. PubMed ID: 34244101
    [No Abstract]   [Full Text] [Related]  

  • 44. Botulinum toxin-A: evaluation of the influence on the aspect of trunk scars.
    Baldissera RL; Lehmkuhl RL; Schmitt JV; Torre DS
    An Bras Dermatol; 2021; 96(3):362-364. PubMed ID: 33867191
    [No Abstract]   [Full Text] [Related]  

  • 45. Appropriate Timing of Early Postoperative Botulinum Toxin Type A Injection for Thyroidectomy Scar Management: A Split-Scar Study.
    An MK; Cho EB; Park EJ; Kim KH; Kim LS; Kim KJ
    Plast Reconstr Surg; 2019 Oct; 144(4):659e-668e. PubMed ID: 31568312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids.
    Ahuja RB; Chatterjee P
    Burns; 2014 Jun; 40(4):583-8. PubMed ID: 24182692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial.
    Huang RL; Ho CK; Tremp M; Xie Y; Li Q; Zan T
    Plast Reconstr Surg; 2019 Oct; 144(4):835-844. PubMed ID: 31568286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Commentary on: Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials.
    Walsh M
    Aesthet Surg J; 2021 May; 41(6):NP576-NP578. PubMed ID: 33515238
    [No Abstract]   [Full Text] [Related]  

  • 49. Invited Response on: Comment on: "Botulinum Toxin Type A Injection for Mammoplasty and Abdominoplasty Scar Management: A Split-Scar Double-Blinded Randomized Controlled Study".
    Abedini R; Nasimi M; Mehdizade Rayeni N
    Aesthetic Plast Surg; 2021 Oct; 45(5):2537-2538. PubMed ID: 33834293
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and Safety of Intralesional Triamcinolone Versus Combination of Triamcinolone with 5-Fluorouracil in the Treatment of Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis.
    Jiang ZY; Liao XC; Liu MZ; Fu ZH; Min DH; Yu XT; Guo GH
    Aesthetic Plast Surg; 2020 Oct; 44(5):1859-1868. PubMed ID: 32342167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Austin E; Koo E; Jagdeo J
    Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative Clinical Indications of Botulinum Toxin.
    Alster TS; Harrison IS
    Am J Clin Dermatol; 2020 Dec; 21(6):855-880. PubMed ID: 32651806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.
    Park GS; An MK; Yoon JH; Park SS; Koh SH; Mauro TM; Cho EB; Park EJ; Kim KH; Kim KJ
    Arch Dermatol Res; 2019 Dec; 311(10):807-814. PubMed ID: 31501922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of botulinum toxin type a on collagen deposition in hypertrophic scars.
    Xiao Z; Qu G
    Molecules; 2012 Feb; 17(2):2169-77. PubMed ID: 22354193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial.
    Kim YS; Lee HJ; Cho SH; Lee JD; Kim HS
    Wound Repair Regen; 2014; 22(5):605-12. PubMed ID: 24898579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research advances on application of botulinum toxin type A in scar prevention and treatment].
    Yu Z; Ren P; Zhang H; Chen H; Ma FX
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Apr; 38(4):385-388. PubMed ID: 35462519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local Injection of Botulinum Toxin Type A to Prevent Postoperative Scar.
    Chen S; Yang Y; Zhang D; Liu Y; Li Y
    J Craniofac Surg; 2020; 31(2):440-443. PubMed ID: 31977704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial.
    Chang CS; Wallace CG; Hsiao YC; Chang CJ; Chen PK
    PLoS One; 2014; 9(12):e115690. PubMed ID: 25541942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin type A as a novel method of preventing cleft lip scar hypertrophy-A literature review.
    Bartkowska P; Roszak J; Ostrowski H; Komisarek O
    J Cosmet Dermatol; 2020 Sep; 19(9):2188-2193. PubMed ID: 32654297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of Botulinum Toxin A for Scar Prevention After Breast Augmentation: A Randomized Double-Blind Intraindividual Controlled Trial.
    Disphanurat W; Viarasilpa W; Thienpaitoon P
    Dermatol Surg; 2021 Dec; 47(12):1573-1578. PubMed ID: 34818273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.